ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Medplus subsidiary Optival Health received a two-day drug licence suspension for its Kothagudem store. Expected financial impact is Rs 0.44 lacs, and compliance measures are underway.
MedPlus stores in Karnataka face four-day drug licence suspensions. Expected financial impact is about Rs 4.06 lacs.
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
Optival Health, a MedPlus subsidiary, had drug licences suspended at five Karnataka stores for 1–7 days. Expected impact is about Rs 8.66 lakhs.
Medplus Health Services' subsidiary Optival Health faced temporary drug license suspensions for two stores by Mysore regulators. The estimated operational impact is ₹0.02 Crore.
The FDA suspended the drug license of a Medplus subsidiary's store in Prabhadevi, Maharashtra for 15 days. The financial impact is estimated at Rs 14.25 lakhs.
Medplus Health's subsidiary Optival Health faces drug license suspensions for 5-8 days across four stores in multiple states. The expected financial impact is ₹0.17 Crore.
Optival Health Solutions, a subsidiary, received a one-day drug license suspension from the Drugs Control Administration for a violation of the Drugs and Cosmetics Act.
Optival Health Solutions, a subsidiary of Medplus Health Services, received a 4-day drug license suspension for an Odisha store, impacting financials by ₹0.02 Crore.
Medplus Health Services subsidiary Optival Health faces a seven-day drug license suspension at a Karnataka store. The financial impact of this regulatory action is ₹0.12 Crore.
Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.
Medplus Health Services reported a 7-day drug license suspension for a subsidiary store, impacting its operations with an estimated financial loss of ₹0.02 Crore.